Cargando…

Potential of circulating lncRNA CASC2 as a biomarker in reflecting the inflammatory cytokines, multi‐organ dysfunction, disease severity, and mortality in sepsis patients

BACKGROUND: Long noncoding RNA (lncRNA) cancer susceptibility candidate gene 2 (CASC2) inhibits inflammation and multi‐organ dysfunction in various ways. The present study was intended to explore the potency of blood lncRNA CASC2 as a biomarker for sepsis management. METHODS: Totally, 184 sepsis pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Rui, Zhao, Jinglin, Wei, Qi, Wang, Hao, Zhao, Chao, Hu, Caihong, Han, Yu, Hui, Zhi, Yang, Long, Dai, Qingchun, Liu, Cuicui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396177/
https://www.ncbi.nlm.nih.gov/pubmed/35754113
http://dx.doi.org/10.1002/jcla.24569
_version_ 1784771871175081984
author Wang, Rui
Zhao, Jinglin
Wei, Qi
Wang, Hao
Zhao, Chao
Hu, Caihong
Han, Yu
Hui, Zhi
Yang, Long
Dai, Qingchun
Liu, Cuicui
author_facet Wang, Rui
Zhao, Jinglin
Wei, Qi
Wang, Hao
Zhao, Chao
Hu, Caihong
Han, Yu
Hui, Zhi
Yang, Long
Dai, Qingchun
Liu, Cuicui
author_sort Wang, Rui
collection PubMed
description BACKGROUND: Long noncoding RNA (lncRNA) cancer susceptibility candidate gene 2 (CASC2) inhibits inflammation and multi‐organ dysfunction in various ways. The present study was intended to explore the potency of blood lncRNA CASC2 as a biomarker for sepsis management. METHODS: Totally, 184 sepsis patients and 30 healthy controls were enrolled. The reverse transcription‐quantitative polymerase chain reaction was used to detect lncRNA CASC2 expression in peripheral blood mononuclear cell samples from the subjects. Mortality during 28 days was recorded in sepsis patients. RESULTS: LncRNA CASC2 was decreased in sepsis patients [median (interquartile range [IQR]): 0.473 (0.241–0.773)] by comparison to healthy controls [median (IQR): 1.019 (0.676–1.685)] (p < 0.001). In sepsis patients, lncRNA CASC2 was negatively correlated with Acute Physiology and Chronic Health Evaluation II (APACHE II) (p = 0.001), Sequential Organ Failure Assessment (SOFA) (p < 0.001), SOFA‐respiratory system (p = 0.010), SOFA‐coagulation (p = 0.020), SOFA‐liver (p = 0.019), and SOFA‐renal (p = 0.010) scores, but was not related to SOFA‐nervous (p = 0.466) and SOFA‐cardio vascular system (p = 0.059) scores. Additionally, lncRNA CASC2 was negatively related to tumor necrosis factor‐α (p = 0.024), interleukin (IL)‐1β (p = 0.013), and IL‐17A (p = 0.002), but was not linked to IL‐6 (p = 0.112) or IL‐10 (p = 0.074). Furthermore, lncRNA CASC2 was lower in sepsis deaths [median (IQR): 0.286 (0.166–0.475)] than in survivors [median (IQR): 0.534 (0.296–0.811)] (p < 0.001). Simultaneously, Kaplan–Meier (KM) curve analysis also observed that lncRNA CASC2 was inversely related to accumulating mortality in sepsis patients (p = 0.003). While lncRNA CASC2 could independently predict lower mortality risk. CONCLUSION: Circulating lncRNA CASC2 inadequacy indicates the release of inflammatory cytokines, severe multi‐organ injuries, and increased mortality in sepsis patients.
format Online
Article
Text
id pubmed-9396177
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93961772022-08-24 Potential of circulating lncRNA CASC2 as a biomarker in reflecting the inflammatory cytokines, multi‐organ dysfunction, disease severity, and mortality in sepsis patients Wang, Rui Zhao, Jinglin Wei, Qi Wang, Hao Zhao, Chao Hu, Caihong Han, Yu Hui, Zhi Yang, Long Dai, Qingchun Liu, Cuicui J Clin Lab Anal Research Articles BACKGROUND: Long noncoding RNA (lncRNA) cancer susceptibility candidate gene 2 (CASC2) inhibits inflammation and multi‐organ dysfunction in various ways. The present study was intended to explore the potency of blood lncRNA CASC2 as a biomarker for sepsis management. METHODS: Totally, 184 sepsis patients and 30 healthy controls were enrolled. The reverse transcription‐quantitative polymerase chain reaction was used to detect lncRNA CASC2 expression in peripheral blood mononuclear cell samples from the subjects. Mortality during 28 days was recorded in sepsis patients. RESULTS: LncRNA CASC2 was decreased in sepsis patients [median (interquartile range [IQR]): 0.473 (0.241–0.773)] by comparison to healthy controls [median (IQR): 1.019 (0.676–1.685)] (p < 0.001). In sepsis patients, lncRNA CASC2 was negatively correlated with Acute Physiology and Chronic Health Evaluation II (APACHE II) (p = 0.001), Sequential Organ Failure Assessment (SOFA) (p < 0.001), SOFA‐respiratory system (p = 0.010), SOFA‐coagulation (p = 0.020), SOFA‐liver (p = 0.019), and SOFA‐renal (p = 0.010) scores, but was not related to SOFA‐nervous (p = 0.466) and SOFA‐cardio vascular system (p = 0.059) scores. Additionally, lncRNA CASC2 was negatively related to tumor necrosis factor‐α (p = 0.024), interleukin (IL)‐1β (p = 0.013), and IL‐17A (p = 0.002), but was not linked to IL‐6 (p = 0.112) or IL‐10 (p = 0.074). Furthermore, lncRNA CASC2 was lower in sepsis deaths [median (IQR): 0.286 (0.166–0.475)] than in survivors [median (IQR): 0.534 (0.296–0.811)] (p < 0.001). Simultaneously, Kaplan–Meier (KM) curve analysis also observed that lncRNA CASC2 was inversely related to accumulating mortality in sepsis patients (p = 0.003). While lncRNA CASC2 could independently predict lower mortality risk. CONCLUSION: Circulating lncRNA CASC2 inadequacy indicates the release of inflammatory cytokines, severe multi‐organ injuries, and increased mortality in sepsis patients. John Wiley and Sons Inc. 2022-06-26 /pmc/articles/PMC9396177/ /pubmed/35754113 http://dx.doi.org/10.1002/jcla.24569 Text en © 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Wang, Rui
Zhao, Jinglin
Wei, Qi
Wang, Hao
Zhao, Chao
Hu, Caihong
Han, Yu
Hui, Zhi
Yang, Long
Dai, Qingchun
Liu, Cuicui
Potential of circulating lncRNA CASC2 as a biomarker in reflecting the inflammatory cytokines, multi‐organ dysfunction, disease severity, and mortality in sepsis patients
title Potential of circulating lncRNA CASC2 as a biomarker in reflecting the inflammatory cytokines, multi‐organ dysfunction, disease severity, and mortality in sepsis patients
title_full Potential of circulating lncRNA CASC2 as a biomarker in reflecting the inflammatory cytokines, multi‐organ dysfunction, disease severity, and mortality in sepsis patients
title_fullStr Potential of circulating lncRNA CASC2 as a biomarker in reflecting the inflammatory cytokines, multi‐organ dysfunction, disease severity, and mortality in sepsis patients
title_full_unstemmed Potential of circulating lncRNA CASC2 as a biomarker in reflecting the inflammatory cytokines, multi‐organ dysfunction, disease severity, and mortality in sepsis patients
title_short Potential of circulating lncRNA CASC2 as a biomarker in reflecting the inflammatory cytokines, multi‐organ dysfunction, disease severity, and mortality in sepsis patients
title_sort potential of circulating lncrna casc2 as a biomarker in reflecting the inflammatory cytokines, multi‐organ dysfunction, disease severity, and mortality in sepsis patients
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396177/
https://www.ncbi.nlm.nih.gov/pubmed/35754113
http://dx.doi.org/10.1002/jcla.24569
work_keys_str_mv AT wangrui potentialofcirculatinglncrnacasc2asabiomarkerinreflectingtheinflammatorycytokinesmultiorgandysfunctiondiseaseseverityandmortalityinsepsispatients
AT zhaojinglin potentialofcirculatinglncrnacasc2asabiomarkerinreflectingtheinflammatorycytokinesmultiorgandysfunctiondiseaseseverityandmortalityinsepsispatients
AT weiqi potentialofcirculatinglncrnacasc2asabiomarkerinreflectingtheinflammatorycytokinesmultiorgandysfunctiondiseaseseverityandmortalityinsepsispatients
AT wanghao potentialofcirculatinglncrnacasc2asabiomarkerinreflectingtheinflammatorycytokinesmultiorgandysfunctiondiseaseseverityandmortalityinsepsispatients
AT zhaochao potentialofcirculatinglncrnacasc2asabiomarkerinreflectingtheinflammatorycytokinesmultiorgandysfunctiondiseaseseverityandmortalityinsepsispatients
AT hucaihong potentialofcirculatinglncrnacasc2asabiomarkerinreflectingtheinflammatorycytokinesmultiorgandysfunctiondiseaseseverityandmortalityinsepsispatients
AT hanyu potentialofcirculatinglncrnacasc2asabiomarkerinreflectingtheinflammatorycytokinesmultiorgandysfunctiondiseaseseverityandmortalityinsepsispatients
AT huizhi potentialofcirculatinglncrnacasc2asabiomarkerinreflectingtheinflammatorycytokinesmultiorgandysfunctiondiseaseseverityandmortalityinsepsispatients
AT yanglong potentialofcirculatinglncrnacasc2asabiomarkerinreflectingtheinflammatorycytokinesmultiorgandysfunctiondiseaseseverityandmortalityinsepsispatients
AT daiqingchun potentialofcirculatinglncrnacasc2asabiomarkerinreflectingtheinflammatorycytokinesmultiorgandysfunctiondiseaseseverityandmortalityinsepsispatients
AT liucuicui potentialofcirculatinglncrnacasc2asabiomarkerinreflectingtheinflammatorycytokinesmultiorgandysfunctiondiseaseseverityandmortalityinsepsispatients